Proteomics/peptidomics tools to find CSF biomarkers for neurodegenerative diseases

23Citations
Citations of this article
35Readers
Mendeley users who have this article in their library.

Abstract

Neurodegenerative diseases are characterized by premature neuronal loss in specific brain regions. During the past decades our knowledge on molecular mechanisms underlying neurodegeneration has increased immensely and resulted in promising drug candidates that might slow down or even stop the neuronal loss. These advances have put a strong focus on the development of diagnostic tools for early or pre-clinical detection of the disorders. In this review we discuss our experience in the field of neuroproteomics/peptidomics, with special focus on biomarker discovery studies that have been performed on CSF samples from well-defined patient and control populations.

Cite

CITATION STYLE

APA

Westman-Brinkmalm, A., Ruetschi, U., Portelius, E., Andreasson, U., Brinkmalm, G., Karlsson, G., … Blennow, K. (2009, January 1). Proteomics/peptidomics tools to find CSF biomarkers for neurodegenerative diseases. Frontiers in Bioscience. Bioscience Research Institute. https://doi.org/10.2741/3341

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free